Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
Funding by Fiscal Year
NIH fiscal year (Oct–Sep)
$1.5M
FY22
$1.6M
FY23
$1.0M
FY24
$1.0M
FY25
By Funding Mechanism
N01
1
R61
1
U54
1
Funding Gap Analysis
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Metachromatic Leukodystrophy. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Biomarker / DiagnosticsPublished, Not NIH-Funded
15 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for metachromatic leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
17 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for metachromatic leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
21 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for metachromatic leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
Translational / Drug DevelopmentPublished, Not NIH-Funded
18 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for metachromatic leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(2 grants)
These grants mention Metachromatic Leukodystrophy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(2)
OtherR01Completed
Development of Assays for Newborn Screening and for Post-Screening Evaluation of Disease Severity
Gelb, Michael·UNIVERSITY OF WASHINGTON·SEATTLE, WA
